{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:39:20Z","timestamp":1789421960856,"version":"build-2803163510"},"reference-count":42,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The objective of this study is to ascertain the predictive criteria for steroid dependence and relapse in patients diagnosed with ulcerative colitis. Additionally, the study aims to provide data that will enable earlier transition to second-line treatment when necessary. Materials and Methods: The study included 62 patients diagnosed with ulcerative colitis between 2018 and 2023, who were followed up at the Department of Pediatric Gastroenterology, Hepatology, and Nutrition at the University of Health Sciences, Izmir Dr. Beh\u00e7et Uz Children\u2019s Hospital. Demographic data included age and gender at diagnosis, BMI, weight-for-age, and height-for-age. Laboratory parameters recorded were complete blood count, total protein, albumin, CRP, ESR, IgG, IgM, IgA, IgG subclasses, vitamin D, B12, folic acid, and ferritin levels. Results: The study included 62 patients. Thirty-two patients (51.6%) were female. In the univariate regression analysis, there was an inverse correlation between IgM levels and relapse and steroid dependence (p &lt; 0.01, p = 0.03, respectively). Additionally, a relationship was identified between steroid dependence and hemoglobin, hematocrit, white blood cell count, neutrophil count, platelet count, and albumin levels (p = 0.01, p &lt; 0.01, p &lt; 0.01, p = 0.01, p &lt; 0.01, p = 0.03, respectively). There was a significant relationship between MMES and steroid dependence (p &lt; 0.01). MMES was found to be significant in predicting steroid dependence in patients with pancolitis (AUC: 0.75, 95% CI: [0.60\u20130.90], p = 0.01). Conclusions: We conclude, as for Crohn\u2019s disease, an algorithm or a specific scoring system for ulcerative colitis is needed for the use of anti-TNF drugs as first-line treatment in pediatric ulcerative colitis. The initial severity of the disease appears to be the most important risk factor in terms of steroid dependence. Based on our study and the literature data, a scoring system incorporating parameters such as hemoglobin, hematocrit, WBC, albumin, platelet, and IgM levels, disease involvement type, initial PUCAI score, and MMES would be prudent to adopt.<\/jats:p>","DOI":"10.3390\/medicina62010045","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T02:07:58Z","timestamp":1766714878000},"page":"45","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prediction of Relapse and Steroid Dependency in Pediatric Ulcerative Colitis"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3126-8686","authenticated-orcid":false,"given":"Mehmet","family":"Onder","sequence":"first","affiliation":[{"name":"Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Health Sciences Dr. Behcet Uz Children\u2019s Hospital, Izmir 35210, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-8686","authenticated-orcid":false,"given":"Cigdem Omur","family":"Ecevit","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Health Sciences Dr. Behcet Uz Children\u2019s Hospital, Izmir 35210, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safak","family":"Pelek","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Health Sciences Dr. Behcet Uz Children\u2019s Hospital, Izmir 35210, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3662-4355","authenticated-orcid":false,"given":"Duygu","family":"Demirtas Guner","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Health Sciences Dr. Behcet Uz Children\u2019s Hospital, Izmir 35210, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulin","family":"Eren","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Health Sciences Dr. Behcet Uz Children\u2019s Hospital, Izmir 35210, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5129-0923","authenticated-orcid":false,"given":"Sevim","family":"Cakar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Dokuz Eylul University, Izmir 35330, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4858-7838","authenticated-orcid":false,"given":"Ozlem","family":"Bekem","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Health Sciences Dr. Behcet Uz Children\u2019s Hospital, Izmir 35210, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MPG.0b013e3182662233","article-title":"Management of Pediatric Ulcerative Colitis","volume":"55","author":"Turner","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/ibd\/izae093","article-title":"Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019","volume":"31","author":"Wang","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ibd.21349","article-title":"Epidemiology of Pediatric Inflammatory Bowel Disease: A Systematic Review of International Trends","volume":"17","author":"Benchimol","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e15511","DOI":"10.1111\/ped.15511","article-title":"Mucosal Immune Systems of Pediatric Inflammatory Bowel Disease: A Review","volume":"65","author":"Kudo","year":"2023","journal-title":"Pediatr. Int."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Baumgart, D.C. (2012). Immunobiology of B Cells in Inflammatory Bowel Disease. Crohn\u2019s Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach, Springer.","DOI":"10.1007\/978-1-4614-0998-4"},{"key":"ref_6","first-page":"e78462","article-title":"Inflammatory Bowel Disease in Children: Current Diagnosis and Treatment Strategies","volume":"17","author":"Bhalla","year":"2025","journal-title":"Cureus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can. J. Gastroenterol. J. Can. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ibd.21493","article-title":"Pediatric Modification of the Montreal Classification for Inflammatory Bowel Disease: The Paris Classification","volume":"17","author":"Levine","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/ibd.20867","article-title":"Appraisal of the Pediatric Ulcerative Colitis Activity Index (PUCAI)","volume":"15","author":"Turner","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2468-1253(17)30252-2","article-title":"Factors Associated with Early Outcomes Following Standardised Therapy in Children with Ulcerative Colitis (PROTECT): A Multicentre Inception Cohort Study","volume":"2","author":"Hyams","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cgh.2009.06.024","article-title":"A Systematic Prospective Comparison of Noninvasive Disease Activity Indices in Ulcerative Colitis","volume":"7","author":"Turner","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jpn3.70097","article-title":"Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care\u2014An Updated Evidence-based Consensus Guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn\u2019s and Colitis Organisation","volume":"81","author":"Wine","year":"2025","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ibd\/izad064","article-title":"Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN","volume":"30","author":"Olbjorn","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ecco-jcc\/jjaa161","article-title":"The Medical Management of Paediatric Crohn\u2019s Disease: An ECCO-ESPGHAN Guideline Update","volume":"15","author":"Aloi","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/S0140-6736(18)32592-3","article-title":"Clinical and Biological Predictors of Response to Standardised Paediatric Colitis Therapy: A Multicentre Inception Cohort Study","volume":"393","author":"Hyams","year":"2019","journal-title":"Lancet Lond. Engl."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/apt.18262","article-title":"CEDATA-GPGE Study Group Predicting Complications in Paediatric Ulcerative Colitis: A Longitudinal Multicentre Cohort Study","volume":"60","author":"Schiller","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.gastro.2020.07.066","article-title":"Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program","volume":"160","author":"Aardoom","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1016\/j.crohns.2013.03.007","article-title":"Presenting Features and Disease Course of Pediatric Ulcerative Colitis","volume":"7","author":"Aloi","year":"2013","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00535-023-01972-1","article-title":"Clinical Outcome of Ulcerative Colitis with Severe Onset in Children: A Multicenter Prospective Cohort Study","volume":"58","author":"Nambu","year":"2023","journal-title":"J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3345\/cep.2024.01144","article-title":"Outcome of Pediatric Inflammatory Bowel Disease in Asian Children: A Multinational 1-Year Follow-up Study","volume":"68","author":"Tanpowpong","year":"2025","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/ecco-jcc\/jjv111","article-title":"The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients","volume":"9","author":"Bessissow","year":"2015","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/gut.35.3.360","article-title":"Frequency of Glucocorticoid Resistance and Dependency in Crohn\u2019s Disease","volume":"35","author":"Munkholm","year":"1994","journal-title":"Gut"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MPG.0000000000002035","article-title":"Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-Based Guideline from European Crohn\u2019s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"67","author":"Turner","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Elhag, D.A., Kumar, M., Saadaoui, M., Akobeng, A.K., Al-Mudahka, F., Elawad, M., and Al Khodor, S. (2022). Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23136966"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tanpowpong, P., Jitwongwai, S., Kijmassuwan, T., Sriphongphankul, H., Osatakul, S., Damrongmanee, A., Ukarapol, N., and Treepongkaruna, S. (2024). Multicenter Registry of Pediatric Inflammatory Bowel Disease from a Developing Country. BMC Pediatr., 24.","DOI":"10.1186\/s12887-024-04698-y"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.dld.2019.09.008","article-title":"Long-Term Outcome of Immunomodulator Use in Pediatric Patients with Inflammatory Bowel Disease","volume":"52","author":"Hoffman","year":"2020","journal-title":"Dig. Liver Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/apt.14070","article-title":"DOCHAS Study A Rising Incidence and Poorer Male Outcomes Characterise Early Onset Paediatric Inflammatory Bowel Disease","volume":"45","author":"Coughlan","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MPG.0000000000001941","article-title":"Early Treatment Response Predicts Outcome in Paediatric Ulcerative Colitis: GASTROENTEROLOGY: INFLAMMATORY BOWEL DISEASE","volume":"67","author":"Gasparetto","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1007\/s00431-024-05554-y","article-title":"Fecal Calprotectin and Platelet Count Predict Histologic Disease Activity in Pediatric Ulcerative Colitis: Results from a Projection-Predictive Feature Selection","volume":"183","author":"Schiller","year":"2024","journal-title":"Eur. J. Pediatr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/ecco-jcc\/jjad052","article-title":"Multiomics-Empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States","volume":"17","author":"Janker","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5009\/gnl17236","article-title":"An Elevated Platelet Count Increases the Risk of Relapse in Ulcerative Colitis Patients with Mucosal Healing","volume":"12","author":"Nakarai","year":"2018","journal-title":"Gut Liver"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/gutjnl-2014-306999","article-title":"Early Endoscopic, Laboratory and Clinical Predictors of Poor Disease Course in Paediatric Ulcerative Colitis","volume":"64","author":"Schechter","year":"2015","journal-title":"Gut"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00824","DOI":"10.14309\/ctg.0000000000000824","article-title":"Neutrophil-to-Lymphocyte Ratio at Diagnosis Predicts Colonoscopic Activity in Pediatric Inflammatory Bowel Diseases","volume":"16","author":"Aziz","year":"2025","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1440-1746.2011.06688.x","article-title":"Clinical Outcomes and Factors for Response Prediction after the First Course of Corticosteroid Therapy in Patients with Active Ulcerative Colitis","volume":"26","author":"Yoon","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/ecco-jcc\/jjw116","article-title":"Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases","volume":"10","author":"Torres","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Song, D.J., Shen, J., Chen, M.H., Liu, Z.J., Cao, Q., Hu, P.J., Gao, X., Qian, J.M., Wu, K.C., and Lai, L.J. (2021). Association of Serum Immunoglobulins Levels With Specific Disease Phenotypes of Crohn\u2019s Disease: A Multicenter Analysis in China. Front. Med., 8.","DOI":"10.3389\/fmed.2021.621337"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"24072","DOI":"10.1038\/srep24072","article-title":"Th17 Responses and Natural IgM Antibodies Are Related to Gut Microbiota Composition in Systemic Lupus Erythematosus Patients","volume":"6","author":"Hevia","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2017.09.013","article-title":"Depressed Serum IgM Levels in SLE Are Restricted to Defined Subgroups","volume":"183","author":"Hardt","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00054725-200301000-00001","article-title":"A Population- and Family-Based Study of Canadian Families Reveals Association of HLA DRB1*0103 with Colonic Involvement in Inflammatory Bowel Disease","volume":"9","author":"Silverberg","year":"2003","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Preisker, S., Brethack, A.-K., Bokemeyer, A., Bettenworth, D., Sina, C., and Derer, S. (2019). Crohn\u2019s Disease Patients in Remission Display an Enhanced Intestinal IgM+ B Cell Count in Concert with a Strong Activation of the Intestinal Complement System. Cells, 8.","DOI":"10.3390\/cells8010078"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/1\/45\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T02:46:36Z","timestamp":1766717196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/1\/45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["medicina62010045"],"URL":"https:\/\/doi.org\/10.3390\/medicina62010045","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]}}}